| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Mr. Thomas Huber CEO | LSE Exchange | CH0013396012 ISIN |
| CH Country | 1,329 Employees | 9 May 2025 Last Dividend | - Last Split | - IPO Date |
SKAN Group AG, originally known as BV Holding AG until its name change in October 2021, is a pioneering provider in the pharmaceutical and chemical industries, offering state-of-the-art isolators, cleanroom devices, and decontamination processes. With a foundational history beginning in 1968, the company has grown to serve a broad international clientele, operating across Asia, Europe, the Americas, and other global locations. SKAN Group AG is headquartered in Allschwil, Switzerland, and operates through two main segments: Equipment and Solutions (E&S) and Services and Consumables (S&C), each addressing critical aspects of pharmaceutical production and maintenance.
This segment provides mission-critical solutions essential for pharmaceutical production. It includes isolators that ensure sterile environments for drug manufacturing, integrated automated systems designed to streamline production processes, and aseptic filling systems and solutions for safe medication packaging. Additionally, SKAN Group offers laboratory and cleanroom equipment, supporting the wide-ranging needs of pharmaceutical and chemical research and production facilities.
SKAN Group’s S&C segment is dedicated to supporting the lifecycle of its equipment and solutions. It provides ready-to-use consumables that facilitate ongoing operations, as well as customer-specific solutions tailored to individual business needs. Furthermore, the segment offers digital solutions aimed at optimizing the equipment usage and production processes. Through these services, SKAN ensures that its clients can maintain continuous, efficient, and high-quality production cycles.